LBF16000PG01: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|SysName=8- [ 2 (R) - (2-Carboxyethyl) -5 (R) -hydroxy-3-oxocyclopentan-1 (R) -yl ] -6-oxooctanoic acid | |SysName=8- [ 2 (R) - (2-Carboxyethyl) -5 (R) -hydroxy-3-oxocyclopentan-1 (R) -yl ] -6-oxooctanoic acid | ||
|Common Name=&&PROSTAGLANDIN E-MAJOR URINARY METABOLITE&& | |Common Name=&&PROSTAGLANDIN E-MAJOR URINARY METABOLITE&& | ||
|Solubility=ETHYL ACETATE | |Solubility=ETHYL ACETATE [[Reference:Hamberg_M:Samuelsson_B:,J. Am. Chem. Soc.,1969,91,2177|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Am. Chem. Soc.,1969,91,2177}}]] | ||
|Mass Spectra=DIMETHYL ESTER DI-O-METHYLOXIME TMS ETHER DERIVATIVE ; m/e 486, 455, 369, 365, 355, 286, 279, 268, 265, 196, 115 | |Mass Spectra=DIMETHYL ESTER DI-O-METHYLOXIME TMS ETHER DERIVATIVE ; m/e 486, 455, 369, 365, 355, 286, 279, 268, 265, 196, 115 [[Reference:Hamberg_M:Samuelsson_B:,J. Am. Chem. Soc.,1969,91,2177|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Am. Chem. Soc.,1969,91,2177}}]] | ||
}} | }} |
Revision as of 00:00, 12 December 2008
IDs and Links | |
---|---|
LipidBank | XPR1421 |
LipidMaps | LMFA03010136 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF16000PG01 |
PROSTAGLANDIN E-MAJOR URINARY METABOLITE | |
---|---|
Structural Information | |
8- [ 2 (R) - (2-Carboxyethyl) -5 (R) -hydroxy-3-oxocyclopentan-1 (R) -yl ] -6-oxooctanoic acid | |
| |
Formula | C16H24O7 |
Exact Mass | 328.152203122 |
Average Mass | 328.35756000000003 |
SMILES | OC(=O)CCCCC(=O)CC[C@@H]([C@H](O)1)[C@@H](CCC(O)=O)C(=O)C1 |
Physicochemical Information | |
ETHYL ACETATE HambergMet al. | |
Spectral Information | |
Mass Spectra | DIMETHYL ESTER DI-O-METHYLOXIME TMS ETHER DERIVATIVE ; m/e 486, 455, 369, 365, 355, 286, 279, 268, 265, 196, 115 HambergMet al. |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|